{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:50:20Z","timestamp":1767340220102},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00347-018-0843-5","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T10:18:51Z","timestamp":1549016331000},"page":"127-137","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Aktuelle und experimentelle Therapieans\u00e4tze bei neurotropher Keratopathie"],"prefix":"10.1007","volume":"116","author":[{"given":"J.","family":"Alder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Menzel-Severing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Geerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"issue":"4","key":"843_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/jcp.25623","volume":"232","author":"L Mastropasqua","year":"2017","unstructured":"Mastropasqua L et\u00a0al (2017) Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves. J\u00a0Cell Physiol 232(4):717\u2013724. \n                    https:\/\/doi.org\/10.1002\/jcp.25623","journal-title":"J Cell Physiol"},{"key":"843_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00347-018-0676-2","volume":"115","author":"C Jacobi","year":"2018","unstructured":"Jacobi C, Messmer EM (2018) Diagnostik des trockenen Auges. Ophthalmologe 115:433\u2013450. \n                    https:\/\/doi.org\/10.1007\/s00347-018-0676-2","journal-title":"Ophthalmologe"},{"issue":"1","key":"843_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00347-004-1161-7","volume":"102","author":"B Seitz","year":"2005","unstructured":"Seitz B et\u00a0al (2005) Konservative und chirurgische Therapie der neurotrophen Keratopathie. Ophthalmologe 102(1):15\u201326. \n                    https:\/\/doi.org\/10.1007\/s00347-004-1161-7","journal-title":"Ophthalmologe"},{"issue":"6","key":"843_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00347-007-1640-8","volume":"105","author":"K Kasper","year":"2008","unstructured":"Kasper K, Kremling C, Geerling G (2008) Toxicity of a\u00a0new moistening agent and preservative in vitro. Ophthalmologe 105(6):557\u2013562. \n                    https:\/\/doi.org\/10.1007\/s00347-007-1640-8","journal-title":"Ophthalmologe"},{"issue":"5","key":"843_CR5","first-page":"948","volume":"42","author":"G Geerling","year":"2001","unstructured":"Geerling G et\u00a0al (2001) Toxicity of natural tear substitutes in a\u00a0fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 42(5):948\u2013956","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"843_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.04.003","author":"[S Dua","year":"2018","unstructured":"Dua S et\u00a0al (2018) Neurotrophic Keratopathy. Prog Retin Eye Res. \n                    https:\/\/doi.org\/10.1016\/j.preteyeres.2018.04.003","journal-title":"Prog Retin Eye Res"},{"key":"843_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00347-003-0950-8","volume":"100","author":"PW Rieck","year":"2003","unstructured":"Rieck PW, Pleyer U (2003) Wundheilung der Hornhaut. Teil II: Therapie von Wundheilungsst\u00f6rungen. Ophthalmologe 100:1109\u20131130. \n                    https:\/\/doi.org\/10.1007\/s00347-003-0950-8","journal-title":"Ophthalmologe"},{"issue":"6","key":"843_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/bjo.2003.027573","volume":"88","author":"JAP Gomes","year":"2004","unstructured":"Gomes JAP et\u00a0al (2004) Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 88(6):821\u2013825. \n                    https:\/\/doi.org\/10.1136\/bjo.2003.027573","journal-title":"Br J Ophthalmol"},{"key":"843_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000131091","volume":"41","author":"G Geerling","year":"2008","unstructured":"Geerling G, Tost FHW (2008) Surgical occlusion of the lacrimal drainage system. Dev Ophthalmol 41:213\u2013229. \n                    https:\/\/doi.org\/10.1159\/000131091","journal-title":"Dev Ophthalmol"},{"key":"843_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000131090","volume":"41","author":"FHW Tost","year":"2008","unstructured":"Tost FHW, Geerling G (2008) Plugs for occlusion of the lacrimal drainage system. Dev Ophthalmol 41:193\u2013212. \n                    https:\/\/doi.org\/10.1159\/000131090","journal-title":"Dev Ophthalmol"},{"issue":"7","key":"843_CR11","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.ophtha.2014.01.028","volume":"121","author":"MM Schornack","year":"2014","unstructured":"Schornack MM, Pyle J, Patel SV (2014) Scleral lenses in the management of ocular surface disease. Ophthalmology 121(7):1398\u20131405. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2014.01.028","journal-title":"Ophthalmology"},{"key":"843_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00347-004-1101-6","volume":"102","author":"KT H\u00e4nisch","year":"2005","unstructured":"H\u00e4nisch KT, Neppert B, Geerling G (2005) Gasdurchl\u00e4ssige Sklerallinsen als konservative Therapiealternative bei extremen Hornhautektasien und schwerem Tr\u00e4nenmangel. Ophthalmologe 102:387\u2013392","journal-title":"Ophthalmologe"},{"issue":"3","key":"843_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/00003226-200005000-00003","volume":"19","author":"RA Ralph","year":"2000","unstructured":"Ralph RA (2000) Tetracyclines and the treatment of corneal stromal ulceration: a review. Cornea 19(3):274\u2013277","journal-title":"Cornea"},{"key":"843_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.1780270415","volume":"27","author":"Robert I. Fox","year":"1984","unstructured":"Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE (1984) Beneficial effect of artificial tears made with autologous serum in patients with Keratoconjunctivitis Sicca. Arthritis Rheum 27(4):459\u2013461","journal-title":"Arthritis & Rheumatism"},{"key":"843_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.209","author":"S Rauz","year":"2017","unstructured":"Rauz S et\u00a0al (2017) The royal college of ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. Eye. \n                    https:\/\/doi.org\/10.1038\/eye.2017.209","journal-title":"Eye"},{"key":"843_CR16","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","volume":"106","author":"Kazuo Tsubota","year":"1999","unstructured":"Tsubota K, Goto E, Shimmura S, Shimazaki J (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10):1984\u20131989","journal-title":"Ophthalmology"},{"key":"843_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/EB.S117261","volume":"10","author":"P Versura","year":"2018","unstructured":"Versura P et\u00a0al (2018) Neurotrophic keratitis: current challenges and future prospects. Eye Brain 10:37\u201345. \n                    https:\/\/doi.org\/10.2147\/EB.S117261","journal-title":"Eye Brain"},{"key":"843_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","volume":"243","author":"L Liu","year":"2005","unstructured":"Liu L et\u00a0al (2005) An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243:706\u2013714. \n                    https:\/\/doi.org\/10.1007\/s00417-004-1106-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"843_CR19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00417-006-0257-y","volume":"244","author":"S Schrader","year":"2006","unstructured":"Schrader S et\u00a0al (2006) Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefes Arch Clin Exp Ophthalmol 244(10):1345\u20131349. \n                    https:\/\/doi.org\/10.1007\/s00417-006-0257-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"843_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","volume":"111","author":"Yukihiro Matsumoto","year":"2004","unstructured":"Yukihiro Matsumoto et\u00a0al (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111(6):1115\u20131120. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2003.10.019","journal-title":"Ophthalmology"},{"issue":"8","key":"843_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.oftal.2012.09.033","volume":"88","author":"AM Guadilla","year":"2013","unstructured":"Guadilla AM et\u00a0al (2013) Effectiveness of topical autologous serum treatment in neurotrophic keratopathy. Arch Soc Esp Oftalmol 88(8):302\u2013306. \n                    https:\/\/doi.org\/10.1016\/j.oftal.2012.09.033","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"6","key":"843_CR22","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1167\/iovs.05-0876","volume":"47","author":"Lei Liu","year":"2006","unstructured":"Lei Liu et al (2006) Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 47(6):2438\u20132444. \n                    https:\/\/doi.org\/10.1167\/iovs.05-0876","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"843_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bjo.2009.164780","volume":"94","author":"K Rao","year":"2010","unstructured":"Rao K, Leveque C, Pflugfelder SC (2010) Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapy. Br J Ophthalmol 94(5):584\u2013591. \n                    https:\/\/doi.org\/10.1136\/bjo.2009.164780","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"843_CR24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.0041-1132.2004.04079.x","volume":"44","author":"D Hartwig","year":"2004","unstructured":"Hartwig D et\u00a0al (2004) Epitheliotrophic capacity of a\u00a0growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 44(12):1724\u20131731. \n                    https:\/\/doi.org\/10.1111\/j.0041-1132.2004.04079.x","journal-title":"Transfusion"},{"issue":"3","key":"843_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-2008-1027199","volume":"225","author":"S Harloff","year":"2008","unstructured":"Harloff S et\u00a0al (2008) Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis. Klin Monbl Augenheilkd 225(3):200\u2013206. \n                    https:\/\/doi.org\/10.1055\/s-2008-1027199","journal-title":"Klin Monbl Augenheilkd"},{"key":"843_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00347-008-1776-1","volume":"105","author":"K Kasper","year":"2008","unstructured":"Kasper K et\u00a0al (2008) On the use of autologous serum eyedrops in Germany\u202f: results of a\u00a0survey among members of the Cornea Section of the German Ophthalmological Society (DOG). Ophthalmologe 105:644\u2013649. \n                    https:\/\/doi.org\/10.1007\/s00347-008-1776-1","journal-title":"Ophthalmologe"},{"issue":"9","key":"843_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","volume":"125","author":"Stefano Bonini","year":"2018","unstructured":"Stefano Bonini et al (2018) Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology 125(9):1332\u20131343. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2018.02.022","journal-title":"Ophthalmology"},{"issue":"8","key":"843_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","volume":"20","author":"CB Cosar","year":"2001","unstructured":"Cosar CB et\u00a0al (2001) Tarsorrhaphy: clinical experience from a\u00a0cornea practice. Cornea 20(8):787\u2013791","journal-title":"Cornea"},{"issue":"9","key":"843_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00347-007-1611-0","volume":"104","author":"R-L Mert\u00e9","year":"2007","unstructured":"Mert\u00e9 R\u2011L, Lanzl IM (2007) Botulinumtoxin-Injektionen zur Erzeugung einer Ptosis. Ophthalmologe 104(9):767\u2013770. \n                    https:\/\/doi.org\/10.1007\/s00347-007-1611-0","journal-title":"Ophthalmologe"},{"issue":"8","key":"843_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00347-016-0377-7","volume":"114","author":"A Schilimow","year":"2017","unstructured":"Schilimow A, Wiechens B (2017) Medikament\u00f6se Oberlidptosis in der Therapie der rezidivierenden Epitheldefekte infolge neurotropher Keratopathie. Ophthalmologe 114(8):745\u2013747. \n                    https:\/\/doi.org\/10.1007\/s00347-016-0377-7","journal-title":"Ophthalmologe"},{"issue":"1","key":"843_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/bjo.86.1.43","volume":"86","author":"DJ Keegan","year":"2002","unstructured":"Keegan DJ et\u00a0al (2002) Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol 86(1):43\u201346","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"843_CR32","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00347-007-1661-3","volume":"104","author":"B Seitz","year":"2007","unstructured":"Seitz B (2007) Amnionmembrantransplantation: Eine unverzichtbare Therapieoption bei persistierenden kornealen Epitheldefekten. Ophthalmologe 104(12):1075\u20131079. \n                    https:\/\/doi.org\/10.1007\/s00347-007-1661-3","journal-title":"Ophthalmologe"},{"key":"843_CR33","unstructured":"o.\u2009A. (2018) Neue Aspekte in Diagnostik und Therapie der neurotrophen Keratopathie. Z prakt Augenheilkd 39(Suppl\u00a06):1\u20138"},{"issue":"4","key":"843_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/bjo.83.4.399","volume":"83","author":"A Azuara-Blanco","year":"1999","unstructured":"Azuara-Blanco A, Pillai CT, Dua HS (1999) Amniotic membrane transplantation for ocular surface reconstruction.  Br J Ophthalmol 83(4):399\u2013402","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"843_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/ICO.0000000000000673","volume":"35","author":"MG Bomfim Pereira","year":"2016","unstructured":"Bomfim Pereira MG et\u00a0al (2016) Cytokine dosage in fresh and preserved human amniotic membrane. Cornea 35(1):89\u201394. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000000673","journal-title":"Cornea"},{"issue":"6","key":"843_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/bjo.2006.108134","volume":"91","author":"C Cursiefen","year":"2007","unstructured":"Cursiefen C et\u00a0al (2007) Amniotic membrane\u2010covered bio\u2010onlays for treatment of ocular surface disease. Br J Ophthalmol 91(6):841\u2013842. \n                    https:\/\/doi.org\/10.1136\/bjo.2006.108134","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"843_CR37","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0161-6420(99)90444-X","volume":"106","author":"FE Kruse","year":"1999","unstructured":"Kruse FE, Rohrschneider K, V\u00f6lcker HE (1999) Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106(8):1504\u20131510. \n                    https:\/\/doi.org\/10.1016\/S0161-6420(99)90444-X\n                    \n                   (discussion 1511)","journal-title":"Ophthalmology"},{"issue":"6","key":"843_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/01.ico.0000153102.19776.80","volume":"24","author":"Sudarshan Khokhar","year":"2005","unstructured":"Sudarshan Khokhar et\u00a0al (2005) Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea 24(6):654\u2013660","journal-title":"Cornea"},{"issue":"4","key":"843_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/ICU.0000000000000484","volume":"29","author":"S Tuli","year":"2018","unstructured":"Tuli S, Gray M, Shah A (2018) Surgical management of herpetic keratitis. Curr Opin Ophthalmol 29(4):347\u2013354. \n                    https:\/\/doi.org\/10.1097\/ICU.0000000000000484","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"843_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/PRS.0b013e3181904d3a","volume":"123","author":"JK Terzis","year":"2009","unstructured":"Terzis JK, Dryer MM, Bodner BI (2009) Corneal neurotization: a novel solution to neurotrophic keratopathy. Plast Reconstr Surg 123(1):112\u2013120. \n                    https:\/\/doi.org\/10.1097\/PRS.0b013e3181904d3a","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"843_CR41","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jamaophthalmol.2014.2316","volume":"132","author":"U Elbaz","year":"2014","unstructured":"Elbaz U et\u00a0al (2014) Restoration of corneal sensation with regional nerve transfers and nerve grafts: a new approach to a\u00a0difficult problem. JAMA Ophthalmol 132(11):1289\u20131295. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2316","journal-title":"JAMA Ophthalmol"},{"key":"843_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/01.GOX.0000533887.29217.6e","author":"J Catapano","year":"2018","unstructured":"Catapano J, Antonyshyn K, Borschel GH (2018) Abstract 22: corneal neurotization improves ocular surface health and prevents corneal scarring in A rat model of neurotrophic keratopathy. Plast Reconstr Surg Glob Open. \n                    https:\/\/doi.org\/10.1097\/01.GOX.0000533887.29217.6e","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"843_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jcjo.2017.10.044","volume":"53","author":"E Weis","year":"2018","unstructured":"Weis E et\u00a0al (2018) Sural nerve graft for neurotrophic keratitis: early results. Can J Ophthalmol 53(1):24\u201329. \n                    https:\/\/doi.org\/10.1016\/j.jcjo.2017.10.044","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"843_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/ICO.0000000000001315","volume":"37","author":"SSM Fung","year":"2018","unstructured":"Fung SSM et\u00a0al (2018) In vivo confocal microscopy reveals corneal reinnervation after treatment of neurotrophic keratopathy with corneal neurotization. Cornea 37(1):109\u2013112. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000001315","journal-title":"Cornea"},{"issue":"5","key":"843_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/ICO.0000000000001522","volume":"37","author":"DSJ Ting","year":"2018","unstructured":"Ting DSJ et\u00a0al (2018) Corneal neurotization for neurotrophic keratopathy: clinical outcomes and in vivo confocal microscopic and histopathological findings. Cornea 37(5):641\u2013646. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000001522","journal-title":"Cornea"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-018-0843-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0843-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0843-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:10:23Z","timestamp":1580515823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-018-0843-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1007\/s00347-018-0843-5","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"1 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Alder, S.\u00a0Mertsch und J.\u00a0Menzel-Severing geben an, dass kein Interessenkonflikt besteht. G.\u00a0Geerling gibt T\u00e4tigkeiten als Berater und Vortragender f\u00fcr Domp\u00e9 Farmaceutici an und hat Mittel f\u00fcr die Durchf\u00fchrung eines selbstinitiierten Forschungsprojektes von Domp\u00e9 Farmaceutici erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. \u00dcber Bildmaterialien und andere Angaben innerhalb des Manuskripts sind keine Patienten identifizierbar.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}